Fumitremorgins and Relatives – From Tremorgenic Compounds to Valuable Anti-Cancer Drugs

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|25|2|123-140

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.25, Iss.2, 2018-01, pp. : 123-140

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An update on ethnic differences in drug metabolism and toxicity from anti-cancer drugs

By Phan Viet Hong   Tan Cindy   Rittau Anneliese   Xu Hongmei   McLachlan Andrew J   Clarke Stephen J  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 11, 2011-11 ,pp. : 1395-1410

Informa Healthcare

Access to resources Recommend Favorite

Modulators of Acetylcholinesterase Activity: From Alzheimer's Disease to Anti-Cancer Drugs

By  

Current Medicinal Chemistry, Vol. 24, Iss. 30, 2017-10 ,pp. : 3283-3309

Bentham Science Publishers

Access to resources Recommend Favorite

Tissue Transport of Anti-cancer Drugs

By  

Current Pharmaceutical Design, Vol. 8, Iss. 22, 2002-10 ,pp. : 1987-1993

Bentham Science Publishers

Access to resources Recommend Favorite

Platinum(II) and Palladium(II) Complex Compounds as Anti-cancer Drugs. Methods of Cytotoxicity Determination

By  

Current Pharmaceutical Analysis, Vol. 10, Iss. 1, 2014-02 ,pp. : 2-9

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Cancer Drugs of Today and Tomorrow: Are we Close to Making the Turn from Treating to Curing Cancer?

By  

Current Pharmaceutical Design, Vol. 8, Iss. 19, 2002-09 ,pp. : 1723-1734

Bentham Science Publishers

Access to resources Recommend Favorite